Impacto de la docencia online en el rendimiento académico de estudiantes españoles de medicina / The impact of online teaching on the academic performance of spanish medical students

Introducción: El confinamiento derivado de la situación sanitaria a finales del primer trimestre de 2020 en España obligó a que la segunda parte del curso 2019-2020 de todos los niveles educativos pasara a formato online de una manera forzada e imprevista. Objetivo: Identificar el impacto de la docencia online en el rendimiento académico de los estudiantes de medicina en el curso 2019-2020. Métodos: El estudio fue de tipo transversal y utilizó datos públicos anonimizados sobre rendimiento académico de estudiantes de medicina en universidades españolas. A partir de la información pública de los sistemas de garantía interna de calidad de estas universidades, se analizaron los valores medios de las tasas de rendimiento y éxito de los cuatro cursos comprendidos entre 2015 y 2019 en 17 universidades españolas. Estos se compararon mediante una prueba t de Student con los obtenidos en el curso 2019-2020. Resultados: Las tasas de rendimiento y éxito fueron superiores en el curso 2019-2020 en comparación con la media de los cuatro cursos anteriores. Conclusiones: La situación de confinamiento y de cambio forzado a docencia online parece haber producido una mejora en el ya de por sí elevado rendimiento académico de los estudiantes de medicina, lo que sugiere niveles elevados de resiliencia y una buena capacidad de adaptación a una situación adversa como la experimentada en la segunda parte del curso 2019-2020 (AU)

Introduction: The lockdown derived from the health situation at the end of the first quarter of 2020 in Spain forced the second part of the 2019-2020 academic course of all educational levels to be move to the online modality in a compulsory and unforeseen way. Objective: To identify the impact of online teaching on the academic performance of medical students in the 2019-2020 academic year. Methods: The study was cross-sectional and used anonymized public data on the academic performance of medical students in Spanish universities. Based on public information from the internal quality assurance systems of these universities, the mean values of performance and success rates were analyzed for the four academic years between 2015 and 2019 in seventeen Spanish universities. Using a Student's t test, these were compared with those obtained in the 2019-2020 academic year. Results: The performance and success rates were higher in the 2019-2020 academic year compared to the average of the four previous academic years. Conclusions: The situation of lockdown and forced change to online teaching seems to have produced an improvement in the already high academic performance of medical students, being this suggestive of high levels of resilience and a good capacity to adapt to an adverse situation such as the one experienced in the second part of the 2019-2020 academic year(AU)

Factores de riesgo de la enfermedad hepática grasa no alcohólica / Risk factors for non-alcoholic fatty liver disease

Prevalence of non-alcoholic fatty liver disease (NAFLD) may be 10%-15% worldwide, and these figures are even higher in obese and in type 2 diabetes mellitus patients. The most important risk factor is metabolic syndrome, especially central obesity. Even though the majority of patients with macrovesicular steatohepatitis will not progress to advanced liver disease, a subgroup of patients will evolve to non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. Independent risk factors associated with NASH are older age, type 2 diabetes mellitus and obesity. Patients with significant hepatocellular lesion, such as hepatocyte ballooning, Mallory hyalline or fibrosis, have a higher risk of cirrhosis and are more likely to have a high liver-related mortality, although higher global mortality has not been demonstrated. Although NASH related cirrhosis may have better prognosis compared to hepatitis C cirrhosis, recent series suggest that it may be the third cause of liver transplantation. Steatosis, NASH and cirrhosis recurrence post-liver transplantation is common. The risk of hepatocellular carcinoma (HCC) is increased in patients with NAFLD, and all patients with cryptogenic cirrhosis should be screened for HCC

La enfermedad hepática grasa no alcohólica puede afectar al 15%-25% de la población, con cifras mayores en pacientes obesos y con diabetes mellitus tipo 2. El principal factor de riesgo es el síndrome metabólico, especialmente la obesidad central. Aunque la mayoría de los pacientes con esteatosis macrovacuolar simple no presentan progresión de su enfermedad, existe un subgrupo que progresa a esteatohepatitis no alcohólica, y aunque se desconocen los factores de riesgo para esta progresión, la mayoría de los estudios reconocen la edad, la presencia de diabetes mellitas tipo 2 y la obesidad como predictores de riesgo independientes de EHNA. La presencia de lesión hepatocelular significativa, como el abalonamiento hepatocitario o la hialina de Mallory y la fibrosis, incrementan significativamente el riesgo de cirrosis. Los pacientes que tienen esta lesión histopatológica presentan una mortalidad de causa hepática superior, si bien no se ha demostrado una mortalidad global aumentada. Aunque la cirrosis secundaria a esteatohepatitis no alcohólica parece tener un pronóstico ligeramente mejor que la secundaria a hepatitis C, en muchas series es la tercera causa de trasplante ortotópico de hígado. La recurrencia postrasplante de la esteatosis, de la esteatohepatitis no alcohólica y de la cirrosis es frecuente. Existe un aumento del riesgo de hepatocarcinoma en pacientes con enfermedad hepática grasa no alcohólica. En la actualidad se recomienda el seguimiento para la detección precoz de este tumor en todos los pacientes con cirrosis criptogénica

Transarterial chemoembolisation in intermediate-stage hepatocellular carcinoma. Survey on clinical practice in hospitals in the Madrid Region.

BACKGROUND: Transarterial chemoembolisation (TACE), having demonstrated survival benefits, is the treatmentof choice in intermediate-stage hepatocellular carcinoma, although there is great heterogeneity in its clinical application. MATERIAL AND METHODS: A survey was sent to the Madrid Regional hospitals to assess applicability, indications and treatment protocols. The assessment was made overall and according to the type of hospital (groups A vs. B and C). RESULTS: Seventeen out of 22 hospitals responded (8/8 group A, 9/ 14 group B-C). All do/indicate transarterial chemoembolisation, 13/17 at their own facilities. Eight of the 17 hospitals have multidisciplinary groups (5/8 A, 3/9 B-C). Nine hospitals perform > 20 procedures/year (7 group A), and 6 from group B-C request/perform < 10/year. It is performed on an "on-demand" basis in 12/17. In 5 hospitals, all the procedures use drug-eluting beads loaded with doxorubicin. The average number of procedures per patient is 2. The mean time from diagnosis of hepatocellular carcinoma to transarterial chemoembolisation is ≤ 2 months in 16 hospitals. In 11/17 hospitals, response is assessed by computed tomography. Radiological response is measured without specific criteria in 12/17 and the other five hospitals (4 group A) assessed using standardised criteria. CONCLUSION: Uniformity among the Madrid Regional hospitals was found in the indication and treatment regimen. The use of DEB-TACE has become the preferred form of TACE in clinical practice. The differentiating factors for the more specialised hospitals are a larger volume of procedures, decision-making by multidisciplinary committees and assessment of radiological response more likely to be standardised.